fenebrutinib
Showing 1 - 5 of 5
Relapsing Multiple Sclerosis Trial in Worldwide (fenebrutinib, )
Recruiting
- Relapsing Multiple Sclerosis
- Fenebrutinib
- Placebo
-
Fullerton, California
- +16 more
Jan 24, 2023
Relapsing Multiple Sclerosis Trial in Worldwide (fenebrutinib, teriflunomide, )
Recruiting
- Relapsing Multiple Sclerosis
- fenebrutinib
- +2 more
-
Cullman, Alabama
- +138 more
Jan 5, 2023
Relapsing Multiple Sclerosis Trial in Worldwide (fenebrutinib, teriflunomide, )
Recruiting
- Relapsing Multiple Sclerosis
- fenebrutinib
- +2 more
-
Homewood, Alabama
- +156 more
Jan 5, 2023
Multiple Sclerosis, Primary Progressive Trial in Worldwide (fenebrutinib, ocrelizumab, )
Recruiting
- Multiple Sclerosis, Primary Progressive
- fenebrutinib
- +2 more
-
Homewood, Alabama
- +211 more
Jan 5, 2023
Healthy Participants Trial in Madison (Fenebrutinib)
Completed
- Healthy Participants
- Fenebrutinib
-
Madison, WisconsinCovance Clinical Research Unit, Inc
Dec 5, 2018